CRISPR AND THE NEW FRONTIERS OF CARE
Gene editing has the potential to transform the way care is administered and personalized to patients, and its impact is already being felt. In a fireside chat with two pioneers in the development of CRISPR and related technology, hear about the latest advances, the costs and challenges of implementation, and the ethical questions surrounding such innovation.
–John Evans, Chief Executive Officer, Beam Therapeutics
–Feng Zhang, Investigator, McGovern Institute for Brain Research, Massachusetts Institute of Technology
CHILDREN FACING TRAUMA AND GRIEF: THE SILENT EPIDEMIC OF THE 21ST CENTURY
–Julie Kaplow, Ph.D., Vice Chair for Behavioral Health and Head of Psychology, Baylor College of Medicine
Additional programming to be announced